Zepp Health (ZEPP) Cash & Equivalents (2015 - 2025)

Zepp Health has reported Cash & Equivalents for 11 years, with the latest figure at $57.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 37.36% year-over-year to $57.0 million; the trailing twelve-month figure through Dec 2025 stood at $57.0 million (down 37.36% YoY), and the FY2025 full-year result was $57.0 million, down 37.36% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $57.0 million, down from $61.7 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $131809.1 billion in Q4 2023, with the low at $76429.0 in Q1 2025.
• Average Cash & Equivalents over 5 years is $6658.3 billion, with a median of $58.6 billion recorded in 2025.
• Year-over-year, Cash & Equivalents jumped 105731351.96% in 2023 and slumped 100.0% in 2025.
• Tracing ZEPP's Cash & Equivalents over 5 years: stood at $229.7 million in 2021, then sank by 45.72% to $124.7 million in 2022, then surged by 105731351.96% to $131809.1 billion in 2023, then tumbled by 100.0% to $91.1 million in 2024, then sank by 37.36% to $57.0 million in 2025.
• The last three Cash & Equivalents figures came in at $57.0 million (Q4 2025), $61.7 billion (Q3 2025), and $55.4 billion (Q2 2025), per Business Quant data.

Peer Comparison